Novocure Ltd LUNAR Phase 3 Clinical Trial Presentation Transcript
Presentation
Jun 06, 2023 / 07:00PM GMT
=====================
Corporate Participants
=====================
* Ashley Cordova
NovoCure Limited - CFO
* Pritesh Shah
NovoCure Limited - Chief Growth Officer
* William F. Doyle
NovoCure Limited - Executive Chairman
=====================
Conference Call Participants
=====================
* Emily Claudia Bodnar
H.C. Wainwright & Co, LLC, Research Division - VP & Senior Healthcare Analyst
* Jason M. Bednar
Piper Sandler & Co., Research Division - Director & Senior Research Analyst
* Lawrence H. Biegelsen
Wells Fargo Securities, LLC, Research Division - Senior Medical Device Equity Research Analyst
* Na Sun
JPMorgan Chase & Co, Research Division - Analyst
* Corey Langer
* Ticiana Leal
=====================
-
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |